Apollo Management Holdings’s European Biotech Acquisition Corp. Units EBACU Stock Holding History

Apollo Management Holdings’s Portfolio EBACU Stock Details EBACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-99,791	Closed	-$992K	–	302
2021 Q3	$992K	Hold	99,791	–	–	﹤0.01%	128
2021 Q2	$997K	Sell	99,791 -209	-0.2%	-$2.09K	0.01%	90
2021 Q1	$1.01M	Buy	+100,000	New	+$999K	0.01%	119

Other funds holding EBACU

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

PMAM

Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SMA

Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Apollo Management Holdings's EBACU Position: Q4 2021 in Review

Apollo Management Holdings sold out of European Biotech Acquisition Corp. Units (EBACU) in Q4 2021, closing a stake of 99,791 shares — an estimated $992K sold.

Apollo Management Holdings first reported a position in EBACU in Q1 2021 and held it in 3 quarters. The position peaked at $1.01M in Q1 2021. 26 funds tracked by Wall St. Rank hold EBACU as of Q4 2021.

Apollo Management Holdings reported no remaining European Biotech Acquisition Corp. Units position as of Q4 2021 after selling out during the quarter.
Apollo Management Holdings sold 99,791 European Biotech Acquisition Corp. Units shares in Q4 2021, an estimated $992K.
Apollo Management Holdings first reported a position in European Biotech Acquisition Corp. Units in Q1 2021 and held it in 3 quarters.
Apollo Management Holdings's European Biotech Acquisition Corp. Units position peaked at $1.01M in Q1 2021.
26 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Units as of Q4 2021.

Based on Apollo Management Holdings's 13F filing for Q4 2021, filed 14 Feb 2022.